Health Care Company Pays $7.75M To Resolve DEA Drug Diversion Probe

(January 21, 2021, 1:25 PM EST) -- Health care company McLaren Health Care Corp. will pay $7.75 million to resolve a federal investigation that two of its former retail pharmacies violated the Controlled Substances Act by failing to...
To view the full article, register now.